Health tech Mario Aguilar STAT Plus: Biogen turns to telehealth company to boost its postpartum depression drug
Health tech Mario Aguilar STAT Plus: What Kaiser Permanente learned from using Apple Watch tech in Parkinson’s care
Health Tech Newsletter Mario Aguilar STAT Plus: Hospital at Home: Medicare report shows how the experiment is going
Health tech Mario Aguilar STAT Plus: ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales
Health tech Mario Aguilar STAT Plus: Sleep apnea alert on Apple Watch: What does it mean, and how does it work?
Exclusive Lev Facher and Mario Aguilar STAT Plus: Lawmakers push to let telehealth providers keep prescribing stimulants and addiction treatment
Health tech Mario Aguilar STAT Plus: Talkspace offers therapy via Amazon, and 23andMe board members resign
Politics Mario Aguilar and Rachel Cohrs Zhang STAT Plus: House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks
Health tech Mario Aguilar and Casey Ross STAT Plus: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event
Health tech Mario Aguilar STAT Plus: What pharma companies and insurers think about Medicare’s plan to cover digital treatments
Business Mario Aguilar and Timmy Broderick STAT Plus: Apple will offer millions of AirPod users a hearing aid. Can it convince them to use it?
Health tech Mario Aguilar STAT Plus: Apple pushes into sleep apnea detection but health care integration remains unclear
Health tech Mario Aguilar STAT Plus: Highmark reboots coverage of digital treatments, raising hope among DTx companies
Health tech Mario Aguilar STAT Plus: Medicare claims data offer clues on doctors most likely to offer telehealth visits
Exclusive Mario Aguilar STAT Plus: Digital therapeutics pioneer Pear’s treatments get a second life, a year after bankruptcy
Health tech Mario Aguilar STAT Plus: Otsuka prices depression digital therapeutic to make it widely accessible, says it’ll lose money
Health tech Mario Aguilar STAT Plus: Disruptions loom for telehealth providers and patients as Congress inches closer to deadline
